Annual Securities Report — FY2025
What MatsukiyoCocokara & Co. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-18View the original on EDINET
How much it says
62Detailed
What moved here
40named for the first time
Its own wording
62terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
On 1 October 2025, the subsidiary And Company acquired all shares of Shinseido Pharmacy and made it a consolidated subsidiary. On 1 April 2026, it was scheduled to complete a further share acquisition of another company, Universal Drug, as disclosed as a subsequent event. The filing also states that treasury shares were acquired and cancelled, with the cancellation completed on 29 May 2026.
Komori's summary of this document, not the document's own words.62Detailed
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 40 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
91
Very detailed
78
Very detailed
88
Very detailed
0
Almost nothing
50
Typical
68
Detailed
50
Typical
52
Typical
53
Typical
55
Typical
73
Detailed
R&D spendNot disclosedThis document does not carry the figure.
Cash left over472億円Cash from the business, less what went into equipment.
Spent on equipment245億円Plants, machines — things meant to last.
Employees14,293Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.